A Strong Case For Trump’s Military Intervention In Venezuela

Please consider $upporting GDPolitics by scanning the QR code below or clicking on this link

An interesting segment on MSNOW featured Hagar Chemali, who made one of the most coherent and intellectually serious cases yet for President Trump’s military posture toward Venezuela. Going into the segment, the prevailing narrative across television news was nearly unanimous: Trump’s actions were framed as a reckless violation of international law, untethered from any legitimate U.S. national security interest. What Chemali did—methodically and without theatrics—was complicate that narrative in a way most pundits either cannot or will not.

Chemali did not dispute that Trump’s actions strain, and may even violate, existing international legal frameworks. Instead, she argued that focusing exclusively on legality misses the more consequential question of national security. According to Chemali, the post–World War II international system—particularly institutions like the United Nations—has become largely incapable of enforcing the very rules it was designed to uphold. That vacuum, she contends, has been aggressively exploited by rogue states and non-state actors who operate with near impunity, often embedding themselves in fragile or hostile regimes much closer to U.S. shores than many Americans appreciate.

What gives Chemali’s argument particular weight is her background. She is not a partisan talking head or an armchair strategist. Chemali served in senior roles at the U.S. Department of the Treasury, including in the Office of Terrorist Financing and Financial Crimes, where she worked directly on counterterrorism, sanctions policy, and efforts to disrupt the financial networks of hostile states and extremist groups. She also held positions during the Obama administration and has worked closely with interagency national security teams, giving her firsthand exposure to how threats are assessed when cameras are not rolling. In other words, she understands how national security doctrine is applied in practice, not just debated on cable news panels.

From that vantage point, Chemali argues that Venezuela cannot be viewed in isolation. It is not merely a failing state or a humanitarian crisis; it has become a strategic foothold for U.S. adversaries seeking influence in the Western Hemisphere. In that context, she suggests, the United States asserting a policing role in the Americas is less about imperial ambition and more about responding to a security architecture that no longer functions. When international bodies fail to act—or selectively enforce rules—power vacuums do not remain empty for long.

Chemali’s analysis effectively provides the Trump administration with a serious national security rationale that goes beyond bluster or appeals to raw power. It offers a framework for countering the charge that the administration is acting lawlessly by arguing that the law itself has become disconnected from enforcement realities. Whether one agrees with that conclusion or not, it is a far more substantive defense than the caricature of Trump acting on impulse or ego.

Trump has occasionally gestured toward the Monroe Doctrine when addressing Venezuela, at times referring to his own version as the “Donroe Doctrine,” but he has rarely articulated the argument with the clarity or discipline Chemali brings to it. Her explanation distills what the administration seems to believe but has struggled to communicate: that American restraint, in a world where enforcement mechanisms are broken, can itself become a liability. Whether Trump adopts this rationale more explicitly going forward remains to be seen, but Chemali’s intervention may well give the administration an opening to reframe the debate on terms that are strategic rather than merely legalistic.

HHS Secretary Guts Funding For mRNA Vaccine Research

Please consider $upporting GDPolitics by scanning the QR code below or clicking on this link

A troubling segment on MSNOW’s Velshi reported that HHS Secretary Robert F. Kennedy Jr. has moved to gut federal funding for mRNA vaccine research, a decision he reportedly made without offering a credible scientific justification. Researchers have long argued that mRNA technology extends far beyond COVID-era vaccines and holds enormous promise, including the potential to treat—or even cure—certain forms of cancer. For decades, finding a cancer cure has been a central goal of governments and medical institutions worldwide, which makes this abrupt reversal especially alarming to scientists who see mRNA as one of the most promising breakthroughs of the modern era.

According to the report, Secretary Kennedy’s rationale is that mRNA vaccines proved ineffective against upper respiratory illnesses such as COVID and the flu. Yet, as highlighted on the program, he has not publicly produced data or peer-reviewed evidence to substantiate that claim. Critics argue that even if one accepts his premise, it ignores the broader scientific consensus that mRNA’s value lies not only in infectious disease prevention but also in its adaptability for cancer therapies, personalized medicine, and treatments for previously intractable conditions. To many in the medical community, the decision appears less like a science-based reassessment and more like an ideological intervention with far-reaching consequences.

At the same time, it would be disingenuous to ignore the deep controversy surrounding vaccines in general and mRNA technology in particular. A sizable segment of the public believes the government has not always been fully transparent about vaccine risks, choosing instead to emphasize benefits while downplaying potential harms. mRNA technology, because it involves genetic instructions, has become a lightning rod for broader fears about government overreach. Claims—often unsupported—have circulated about mRNA being used for surveillance, social control, or even population reduction, folded into darker narratives about a looming “New World Order.” While these ideas remain firmly outside mainstream science, they have nevertheless shaped public opinion and political behavior.

Viewed through that lens, Kennedy’s move is likely to be celebrated by vaccine skeptics and anti-vaccine activists, many of whom already regard him as a champion of their cause. For them, gutting mRNA funding is not a loss but a victory—proof that resistance to vaccines has finally reached the highest levels of government. Yet the absence of a clear scientific explanation raises an unavoidable question: was this decision driven by evidence, or was it a calculated appeal to a constituency deeply distrustful of vaccines and public health institutions?

What happens next remains uncertain, but one thing is clear: the debate over mRNA funding is far from over. As researchers warn of lost momentum in the fight against cancer and other diseases, and critics cheer what they see as a blow against an overreaching biomedical establishment, the controversy is only likely to intensify. In the end, the fate of mRNA research may say less about science itself and more about how politics, fear, and ideology increasingly shape public health policy.